Find Military Health Affairs and Defense Health Agency policy documents.
If you're having trouble finding what you're looking for, consider using fewer words in your search criteria. Results are limited to content that matches all terms in the search field.
We found - potentially matching ""
Advanced Search Options
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (v), establishes Defense Health Agency's (DHA) procedures to: .Establish the overarching guidance to implement policies and procedures for managing DHA Deputy Assistant Director, Information Operations (DAD IO)/J-6Defense Health Program (DHP) IT resources. The DHA Investment Management Framework is used as an enabler for MHS leadership to make informed transparent financial decisions associated with the DHA DAD IO/J-6 systems, services, and capabilities and will continue to be used in the foreseeable future.
This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.
This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (s), establishes the Defense Health Agency's (DHA) procedures to: a. Set procedures, responsibilities, and implement guidance for administering the DHA RA Program in accordance with federal guidelines. b. Provide, submit, and respond to requests for RAs of qualified individuals with disabilities who are employees or applicants for employment. c. Process RA requests for DHA employees and applicants with disabilities to ensure an appropriate response in a timely manner. Further, these procedures establish criteria for collecting and annually reporting data on the numbers and types of request for RA considered.
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the requirements of References (d) through (y): • Establishes the Defense Health Agency’s (DHA) procedures to implement and maintain a DHA Cybersecurity Program for the Military Health System (MHS) to protect and defend DHA information and Information Technology (IT). • Is effective immediately; it will be converted into DHA-Procedural Instruction (DHA-PI), “Cybersecurity Program Management.” This DHA-IPM will expire effective 12 months from the date of issue.
This PGI provides standard language that shall be included in all purchased and non-purchased care solicitations and contracts where the contractor’s performance involves access to PII/PHI (unless those solicitations and contracts incorporate the TRICARE Manuals in their entirety, in which case this PGI does not apply).
DHA Medicare Billing Guidance Memorandum
DHA Medicare Billing Guidance Attachment A
DHA Medicare Billing Guidance FAQ
CMS Checklist for MTF Claims
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the requirements of References (d) through (y): * Establishes the Defense Health Agency's (DHA) procedures to implement and maintain a DHA Cybersecurity Program for the Military Health System (MHS) to protect and defend DHA information and information technology (IT). * Is effective immediately; it will be converted into DHA-Procedural Instruction (DHA-PI), "Cybersecurity Program Management." This DHA-IPM will expire effective 12 months from the date of issue.
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (f). • Assigns responsibilities, describes procedures, and formalizes the JMESP within the Military Health System (MHS). This program assists in preliminary education and training for commanders or directors of DoD medical treatment facilities (MTFs) and leaders of DHA and TRICARE Regional Offices, to include officers, enlisted, and civilians.
This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (q), establishes the Defense Health Agency’s (DHA) procedures to support the geographic combatant commanders and select functional combatant commanders (CCDRs) (with validated CCDR requirement) to establish a CTS and provide optimal care for all casualties pursuant to Reference (d) and (e).
In accordance with the authority in DoD Directive 5124.02, this issuance establishes policy, assigns responsibilities, and prescribes procedures regarding the standards for military service accession, retention, separation, in-service transition, and medical care for Service members and applicants for accession to the Military Services with gender dysphoria or who are transgender, as applicable.
The Department of Defense (DoD) Pharmacy and Therapeutics (P&T) Committee (henceforth, P&T Committee) is responsible for development and maintenance of the TRICARE Uniform Formulary. This charter outlines the roles and responsibilities of the DoD P&T Committee.
This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (f), establishes the Defense Health Agency’s (DHA) procedures to: a. Provide the DHA organizational Component Director and leadership with an evaluation of the DHA Component’s ability to perform key logistics functions by ensuring standardized, repeatable, and technically compliant processes are executed while promoting a culture of professional excellence and personal responsibility. b. Provide knowledge sharing and Medical Logistics (MEDLOG) automation site support to Military Medical Treatment Facilities (MTF) and DHA Components.
DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101
The appearance of hyperlinks does not constitute endorsement by the Defense Health Agency of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.